Fed slashes interest rates by 25 basis points in 2nd consecutive cut

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

119.35

-8.62

(-6.74%)

As of 02:15PM EST. Market open.

Trade prices are not sourced from all markets

All

Zacks
SRPT Beats on Q3 Earnings & Sales, Discontinues PPMO-Based DMD Program
Sarepta posts encouraging Q3 earnings. After conducting a risk-benefit analysis, the company decides to stop developing the entire PPMO program.
BioPharma Dive
Sarepta scraps a Duchenne drug as gene therapy sales rise
Elevidys sales have increased since the FDA made a controversial choice to expand the therapy's use. Meanwhile, Sarepta is abandoning a successor to its drug Exondys 51, citing an “evolving" treatment landscape.